|
⚲
|
| Keyboard |
| SV7 IMF GP LLP
✚
|
|
|---|---|
| CIK # | 0001889859 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001889859] | |
| 4 | [0001889859] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| SV7 IMF GP LLP | |
| Xilio Therapeutics Inc | |
| SV7 Impact Medicine Fund LP |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Xilio Therapeutics Inc XLO
Common Stock
|
2021-10-26 | Conversion | 998,544 | ||
|
Xilio Therapeutics Inc XLO
Common Stock
|
2021-10-26 | Conversion | 998,544 | ||
|
Xilio Therapeutics Inc XLO
Common Stock
|
2021-10-26 | Conversion | 302,588 | ||
|
Xilio Therapeutics Inc XLO
Common Stock
|
2021-10-26 | Conversion | 302,588 | ||
|
Xilio Therapeutics Inc XLO
Series B Convertible Preferred Stock · derivative
|
2021-10-26 | Conversion | 9,486,166 | $0.00 | |
|
Xilio Therapeutics Inc XLO
Series C Convertible Preferred Stock · derivative
|
2021-10-26 | Conversion | 2,874,595 | $0.00 | |
|
Xilio Therapeutics Inc XLO
Series B Convertible Preferred Stock · derivative
|
2021-10-26 | Conversion | 9,486,166 | $0.00 | |
|
Xilio Therapeutics Inc XLO
Series C Convertible Preferred Stock · derivative
|
2021-10-26 | Conversion | 2,874,595 | $0.00 |